Brand Name Drug Executives Should Commit to Affordable Pricing on COVID-19 Vaccines and Treatments AN OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE The U.S. House of Representatives Committee on Energy…

Analysis Finds Drug Companies Posted Banner Year For Profits and Mergers While Hiking Drug Prices During Pandemic A new report on the pharmaceutical industry from research firm Evaluate Vantage lays…

Brand Name Pharma Companies Continue to Bring in Sky-High Profits While Hiking Prices New fourth quarter earning reports from Big Pharma giants Bristol-Myers Squibb (BMS), Sanofi, Merck, Roche and…

Resource Provides Information on Out-of-Control Drug Prices — Outlines Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable and Deliver Relief for American Patients For Immediate…

Study Finds Solutions to Make Medications More Accessible Will Not Restrict R&D and Breakthrough Cures A new report from Patients for Affordable Drugs (P4AD), “Big Pharma’s Big Lie: The…

Brand Name Pharma Giants Surpass Expectations While Hiking Prices During Pandemic New fourth quarter earnings reports released this week from Big Pharma giants GlaxoSmithKline (GSK) and AbbVie…

Big Pharma Giants See Profits Jump After New Year Price Hikes New earnings reports for the fourth quarter of 2020 show that Big Pharma giants are continuing to rake in big profits while hiking…

Brand Name Drug Company Sees Soaring Profits After Hiking Prices Today, brand name drug giant Eli Lilly announced rising profits for the fourth quarter of 2020 – topping analysts’ expectations.

HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on Holding Big Pharma Accountable in Order to Lower Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884…